Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» No Post-IPO Blues for Endocyte
No Post-IPO Blues for Endocyte
No Post-IPO Blues for Endocyte
Submitted by
admin
on July 13, 2011 - 4:50pm
Source:
Seeking Alpha
News Tags:
IPOs
Endocyte
ovarian cancer
EC145
small molecule drugs
Headline:
No Post-IPO Blues for Endocyte
Do Not Allow Advertisers to Use My Personal information